Publication | Closed Access

Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction

Cardiovascular DiseaseMedicineStem Cell MobilizationMyocardial InfarctionHematologyPlacebo-controlled TrialStem-cell TherapyPhase 1St-elevation Myocardial InfarctionStem CellsCardiologyEmergency MedicineAcute Myocardial InfarctionHealth Sciences